Lab research aims to fix immune defects using Patients' own stem cells
NCT ID NCT01212055
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 17 times
Summary
This study collects blood stem cells from people with DOCK8 deficiency, LAD-1, or GATA2 deficiency to test gene-correction methods in the lab. Participants receive daily injections of a drug to move stem cells into the bloodstream, then donate cells through a procedure called apheresis. The cells are used only for research, not as a treatment. The goal is to learn how to fix these immune defects in a test tube.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOCK8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.